Effect of a Serotonin Precursor and Uptake Inhibitor in Anxiety Disorders; a Double-Blind Comparison of 5-Hydroxytryptophan, Clomipramine and Placebo
The DOI matches its Crossref record.
Abstract
A double-blind placebo-controlled study of 5-HTP and clomipramine was carried out on 45 patients suffering from anxiety disorders (DSM-III). Clomipramine has shown to be effective in that it induced significant improvement on all rating scales as compared to placebo. 5-HTP showed a moderate reduction of the symptomatology on the 90-item symptoms checklist (SCL-90) and the State Scale of the Spielberger State-Trait Anxiety Inventory. Clomipramine and 5-HTP differed in their efficacy in that 5-HTP did not affect the associated depressive symptomatology. The results support the hypothesis that brain serotonergic pathways are involved in the pathogenesis of anxiety disorders, particularly in agoraphobia and panic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hypersexual disorder: A proposed diagnosis for DSM-V
Kafka, M. P. (2010) · Archives of Sexual Behavior · doi:10.1007/s10508-009-9574-7 · Cited by 1,095
Efficacy of Drug Treatment in Obsessive–Compulsive Disorder: a Meta-Analytic Review
Piccinelli, M., Pini, S., Bellantuono, C., & Wilkinson, G. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.4.424 · Cited by 282
van Praag, H. (1987) · Journal of Affective Disorders · doi:10.1016/0165-0327(87)90067-x · Cited by 265
Serotonin and anxiety revisited
Kahn, R. S., van Praag, H. M., Wetzler, S., Asnis, G. M., & Barr, G. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90091-1 · Cited by 258
Self-citationMaffei, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010181 · Cited by 236
“5-HT was found to mediate anxiety [146] and showed a moderate reduction of the symptomatology on the 90-item symptoms checklist (SCL-90) and the state scale of the Spielberger State–Trait Anxiety Inventory, suggesting that brain serotonergic pathways are involved in the pathogenesis of anxiety disorders, particularly…”
Metadata
- Authors
- KAHN, R. S., WESTENBERG, H. G. M., VERHOEVEN, W. M. A., GISPEN-DE WlED, C. C., & KAMERBEEK, W. D. J.
- Venue
- International Clinical Psychopharmacology
- Published
- 1987-01
- Volume
- 2
- Issue
- 1
- Pages
- 33-45
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2081526164
- Cited by
- 106
- References
- 0
- FWCI
- 16.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of a Serotonin Precursor and Uptake Inhibitor in Anxiety Disorders; a Double-Blind Comparison of 5-Hydroxytryptophan, Clomipramine and Placebo. https://app.cochat.ai/papers/10.1097/00004850-198701000-00003
- The paper
- KAHN, R. S., WESTENBERG, H. G. M., VERHOEVEN, W. M. A., GISPEN-DE WlED, C. C., & KAMERBEEK, W. D. J. (1987). Effect of a Serotonin Precursor and Uptake Inhibitor in Anxiety Disorders; a Double-Blind Comparison of 5-Hydroxytryptophan, Clomipramine and Placebo. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-198701000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.